Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in ARS PHARMACEUTICALS INC
RA CAPITAL MANAGEMENT, L.P. holds 10.9M shares of SPRY (ARS PHARMACEUTICALS INC), worth $126.5M as of 2025-Q4. SPRY represents 1.3% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.
Current Value
$126.5M
Current Shares
10.9M
Total Value Change
+$34.1M
Total Shares Change
0
Other major holders of SPRY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BlackRock, Inc., ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC
Unchanged |
| 10.9M |
0.0% |
| $126.5M |
| 1.3% |
| $11.64 |
0 |
| 2025-Q3 | Unchanged | 10.9M | 0.0% | $109.2M | 1.3% | $9.72 | 0 |
| 2025-Q2 | Unchanged | 10.9M | 0.0% | $189.5M | 3.2% | $18.20 | 0 |
| 2025-Q1 | Unchanged | 10.9M | 0.0% | $136.6M | 2.3% | $12.49 | 0 |
| 2024-Q4 | Unchanged | 10.9M | 0.0% | $114.6M | 1.5% | $10.62 | 0 |
| 2024-Q3 | Unchanged | 10.9M | 0.0% | $157.5M | 1.8% | $14.32 | 0 |
| 2024-Q2 | Unchanged | 10.9M | 0.0% | $92.4M | 1.2% | $8.51 | 0 |